Abnormal Mitral Valve Dimensions in Pediatric Patients with Hypertrophic Cardiomyopathy

Daryl Schantz1,2, Lee Benson1, Jonathan Windram3

  • 1Department of Paediatrics, The Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.

Pediatric Cardiology
|March 11, 2016
PubMed

Insights

Children and adolescents with hypertrophic cardiomyopathy (HCM) have significantly longer mitral valve leaflets compared to healthy children. This mitral valve elongation in HCM is not linked to outflow obstruction.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) involves cardiac structural abnormalities beyond myocardial thickening.
  • Adults with HCM exhibit longer mitral valve leaflets compared to controls.
  • Elongated mitral valve leaflets may be a characteristic feature of HCM.

Purpose of the Study:

  • To investigate if pediatric and adolescent patients with HCM also present with elongated mitral valve leaflets.
  • To compare mitral valve leaflet dimensions in pediatric HCM patients versus healthy controls.

Main Methods:

  • Retrospective review of clinical and echocardiographic data from 46 pediatric HCM patients.
  • Evaluation of cardiac magnetic resonance imaging studies.
  • Comparison of anterior and posterior mitral valve leaflet lengths between HCM patients and 20 healthy controls.

Main Results:

  • Patients with HCM showed significantly longer anterior mitral valve leaflets (28.4 ± 4.9 mm) than controls (25.2 ± 3.6 mm, p=0.013).
  • Posterior mitral valve leaflets were also longer in the HCM group (16.3 ± 3.0 mm) compared to controls (13.1 ± 2.3 mm, p<0.0001).
  • No correlation was found between leaflet length and left ventricular outflow tract gradient or systolic anterior motion.

Conclusions:

  • Pediatric and adolescent patients with HCM possess abnormally elongated mitral valve leaflets.
  • Mitral valve elongation in pediatric HCM does not appear to cause or result from left ventricular outflow obstruction.
  • The underlying mechanism for mitral valve elongation in HCM remains unclear and seems independent of hemodynamic factors.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
671
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
404
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
884
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
427
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
932